These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27541930)

  • 21. Electrophysiological actions of the dopamine agonist apomorphine in the paraventricular nucleus during penile erection.
    Richards N; Wayman C; Allers KA
    Neurosci Lett; 2009 Nov; 465(3):242-7. PubMed ID: 19733217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D2 receptors in the basolateral amygdala modulate erectile function in a rat model of nonorganic erectile dysfunction.
    Chen G; Chen J; Yang B; Yu W; Chen Y; Dai Y
    Andrologia; 2019 Feb; 51(1):e13160. PubMed ID: 30276840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy for erectile dysfunction.
    Padma-Nathan H; Christ G; Adaikan G; Becher E; Brock G; Carrier S; Carson C; Corbin J; Francis S; DeBusk R; Eardley I; Hedlund H; Hutter A; Jackson G; Kloner R; Lin CS; McVary K; McCullough A; Nehra A; Porst H; Schulman C; Seftel A; Sharlip I; Stief C; Teloken C
    J Sex Med; 2004 Sep; 1(2):128-40. PubMed ID: 16422967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neural control of erection.
    Giuliano F; Rampin O
    Physiol Behav; 2004 Nov; 83(2):189-201. PubMed ID: 15488539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine.
    Heaton JP
    Neurosci Biobehav Rev; 2000 Jul; 24(5):561-9. PubMed ID: 10880821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase type 5 inhibitors facilitate noncontact erections in male rats: site of action in the brain and mechanism of action.
    Sanna F; Succu S; Boi A; Melis MR; Argiolas A
    J Sex Med; 2009 Oct; 6(10):2680-9. PubMed ID: 19678884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats.
    Melis MR; Melis T; Cocco C; Succu S; Sanna F; Pillolla G; Boi A; Ferri GL; Argiolas A
    Eur J Neurosci; 2007 Aug; 26(4):1026-35. PubMed ID: 17672853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidimensional nature of apomorphine SL (Ixense) therapy.
    Costa P
    Int J Impot Res; 2003 Apr; 15 Suppl 2():S13-5. PubMed ID: 12825099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine and sexual function.
    Giuliano F; Allard J
    Int J Impot Res; 2001 Aug; 13 Suppl 3():S18-28. PubMed ID: 11477488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commentary on apomorphine versus sildenafil for erectile dysfunction.
    Carson CC
    J Urol; 2008 May; 179(5 Suppl):S95-6. PubMed ID: 18405768
    [No Abstract]   [Full Text] [Related]  

  • 31. Tolerability and safety of apomorphine SL (Ixense (TM) ).
    Montorsi F
    Int J Impot Res; 2003 Apr; 15 Suppl 2():S7-9. PubMed ID: 12825097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhalation device allows novel administration of apomorphine in men with erectile dysfunction-efficacy and safety findings.
    Riley A; Main M; Morgan F
    J Sex Med; 2010 Apr; 7(4 Pt 1):1508-17. PubMed ID: 19845547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
    Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
    Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrally acting mechanisms for the treatment of male sexual dysfunction.
    Miner MM; Seftel AD
    Urol Clin North Am; 2007 Nov; 34(4):483-96, v. PubMed ID: 17983889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative review of apomorphine formulations for erectile dysfunction : recommendations for use in the elderly.
    Briganti A; Chun FK; Salonia A; Zanni G; Dehò F; Barbieri L; Karakiewicz PI; Rigatti P; Montorsi F
    Drugs Aging; 2006; 23(4):309-19. PubMed ID: 16732690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future is today: emerging drugs for the treatment of erectile dysfunction.
    Albersen M; Shindel AW; Mwamukonda KB; Lue TF
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):467-80. PubMed ID: 20415601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction.
    Perimenis P; Gyftopoulos K; Giannitsas K; Markou SA; Tsota I; Chrysanthopoulou A; Athanasopoulos A; Barbalias G
    Int J Impot Res; 2004 Feb; 16(1):2-7. PubMed ID: 14963464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine agonist-induced penile erection and yawning: differential role of D₂-like receptor subtypes and correlation with nitric oxide production in the paraventricular nucleus of the hypothalamus of male rats.
    Sanna F; Succu S; Melis MR; Argiolas A
    Behav Brain Res; 2012 May; 230(2):355-64. PubMed ID: 22391116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erectile dysfunction: molecular biology, pathophysiology and pharmacological treatment.
    Morelli A; Vignozzi L; Filippi S; Mancina R; Maggi M
    Minerva Urol Nefrol; 2005 Jun; 57(2):85-90. PubMed ID: 15951732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.